2019Journal of Gynecologic OncologyOpen access

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer

Jeong‐Yeol Park

Open full text 2 citations

Abstract

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer ► See the article "Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers" in volume 31, e10.

Open-access reader

About this research paper

What this paper is about

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer ► See the article "Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers" in volume 31, e10.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer ► See the article "Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers" in volume 31, e10.

Key concepts: Medicine, Venous thromboembolic disease, Thromboembolic disease, Gynecologic cancer, Venous thromboembolism, Cancer, Venous thrombosis, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer — Research Paper | ScholarLens